glp 1 agonist Classification of currently available glucagon-like peptide-1 receptor The New - GLP-1 receptor
Description
Nausea, if it has not already resolved, usually fades
Fytili, C., Nikou, T., Tentolouris, N., Tseti, I.K., Dimosthenopoulos, C., Sfikakis, P.P., Simos, D., Kokkinos, A., Skaltsounis, A.L

(ISBN: 978-1-4052-3648-8)

Innovative designs incorporating active comparators, adaptive frameworks, and biomarker-driven endpoints (e.g., CSF/serum NfL, p-tau, microglial PET, synaptic markers) will be critical to generate interpretable efficacy signals

Diabetologia (2016) 59(5):105969

J Med Assoc Thail Chotmaihet Thangphaet (2010) 93 Suppl 7:S166170
